CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 21 enrolled
Drug / intervention
Neuromuscular electrical stimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00565045
NCT00565045Phase 2Completed

Contralaterally Controlled Functional Electrical Stimulation for Hemiparetic Hand

MetroHealth Medical Center·interventional·Posted Nov 29, 2007·Updated Dec 19, 2018

In Brief

A Phase 2 clinical trial evaluating Neuromuscular electrical stimulator for Stroke, Acute and 3 related conditions. Completed, enrolled 21 participants across 1 site.

Detailed Summary

Impaired hand function is one of the most frequently persisting consequences of stroke. The purpose of this study is to investigate whether two different types of treatment improve recovery of hand function after stroke.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 29, 2007
Enrollment StartJul 1, 2007
Primary CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 18.6 years ago

Interventions

Neuromuscular electrical stimulatordevice

Intervention Characteristics Common to Both Groups • 6-week intervention 1. Home "exercise", daily 1. Exercise (at home) 2 sessions/day 2. A "session" consists of 3 (for CCFES) or 4 (for cNMES) 15-min sets separated by 5 min rest 3. A "set" entails hand opening, closing, and relaxing in response or synchrony to light and sound cues and according to group-specific instructions 2. Lab "therapy", 2x/week 1. Two 1.5-hr sessions/week, working on functional hand tasks and tracking task (if possible).